Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7105 record(s)

Req # A-2020-000450

Adverse Drug Reaction (ADR). Report number: E2B_03076104.

Organization: Health Canada

6 page(s)
April 2024

Req # A-2020-000938

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108812-88, Deputy Minister’s Meeting with Canada’s new Auditor General.

Organization: Health Canada

10 page(s)
April 2024

Req # A-2020-001030

Adverse Drug Reactions (ADRs). Report numbers: 000721620, 000721621, 000721623, 000721654, 000721705, 000721791, 000721858, 000721859, 000722031, 000722048, 000722071, 000722086, 000722112, 000722119, 000722122, 000722123, 000722145, 000722159, 000722166, 000722199.

Organization: Health Canada

315 page(s)
April 2024

Req # A-2020-001430

Adverse Drug Reactions (ADRs). Report numbers: E2B_02959763, E2B_02959832, E2B_02959837, E2B_02960718, E2B_02961718, E2B_02961975, E2B_02962182, E2B_02962222, E2B_02962228, E2B_02962240, E2B_02962267, E2B_02962383, E2B_02962725, E2B_02962736, E2B_02962739, E2B_02962741, E2B_02962742, E2B_02962746, E2B_02962752, E2B_02962762.

Organization: Health Canada

267 page(s)
April 2024

Req # A-2020-001535

Adverse Drug Reactions (ADRs). Report numbers: E2B_03106484, E2B_03107034, E2B_03107273, E2B_03107558, E2B_03107824, E2B_03108501, E2B_03109625, E2B_03110378, E2B_03110399, E2B_03110511, E2B_03110611, E2B_03110675, E2B_03111060, E2B_03111289, E2B_03111329, E2B_03111356, E2B_03111361, E2B_03111425, E2B_03111555, E2B_03111769.

Organization: Health Canada

418 page(s)
April 2024

Req # A-2020-001610

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114416-734.

Organization: Health Canada

24 page(s)
April 2024

Req # A-2021-000028

Adverse Drug Reactions (ADRs). Report numbers: 000928579, E2B_01441318, E2B_03408201, E2B_03408205, E2B_03408767, E2B_03408772, E2B_03409939, E2B_03419846, E2B_03421929, E2B_03422163, E2B_03440717, E2B_03442217, E2B_03443245, E2B_03451400, E2B_03451572, E2B_03455168, E2B_03455178, E2B_03456254, E2B_03456776, E2B_03467997.

Organization: Health Canada

346 page(s)
April 2024

Req # A-2021-000404

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105904-139, Proposed Critical Drug Reserve Procurement Action.

Organization: Health Canada

10 page(s)
April 2024

Req # A-2021-000808

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03467449, E2B_03468879, E2B_03512908, E2B_03487062, 000929339, E2B_03484816, E2B_03507339, E2B_03378451, E2B_03511470, E2B_03464271, E2B_03512885, E2B_03443839, E2B_03282001, E2B_03282980, E2B_03285181, E2B_03479328, E2B_03483393, E2B_03495037, E2B_03281222, E2B_03281717.

Organization: Health Canada

602 page(s)
April 2024

Req # A-2021-001496

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_04403239, E2B_04478607, E2B_04410041, E2B_04374569, E2B_04396043, E2B_04392143, E2B_04370904, E2B_04371940, E2B_04411181, E2B_04411529, E2B_04411619, E2B_04475791, E2B_04399699. ADRs for TECTA. Report numbers: E2B_04373667, E2B_04411326, E2B_04478547, E2B_04358912. ADR for AMPHETAMINES. Report number: 000962432.

Organization: Health Canada

467 page(s)
April 2024
Date modified: